BFEC
TNDM icon

Benjamin F. Edwards & Company’s Tandem Diabetes Care TNDM Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$8K Buy
201
+141
+235% +$5.88K ﹤0.01% 1780
2024
Q1 		$2K Buy
+60
New +$1.61K ﹤0.01% 2047
2020
Q4 		– Sell
-442
Closed -$50K – 1738
2020
Q3 		$50K Buy
442
+100
+29% +$10.5K ﹤0.01% 898
2020
Q2 		$34K Buy
+342
New +$27.3K ﹤0.01% 967
2020
Q1 		– Sell
-38
Closed -$2K – 1883
2019
Q4 		$2K Buy
+38
New +$2.34K ﹤0.01% 1791

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Benjamin F. Edwards & Company's TNDM Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Tandem Diabetes Care (TNDM) stake by 235% in Q2 2024, buying an estimated $5.88K and bringing the position to 201 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Benjamin F. Edwards & Company first reported a position in TNDM in Q4 2019 and has held it in 5 quarters since. The position peaked at $50K in Q3 2020. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

  • Benjamin F. Edwards & Company held 201 shares of Tandem Diabetes Care worth $8K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 141 Tandem Diabetes Care shares in Q2 2024, an estimated $5.88K.
  • Tandem Diabetes Care made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1780 holding.
  • Benjamin F. Edwards & Company first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 5 quarters since.
  • Benjamin F. Edwards & Company's Tandem Diabetes Care position peaked at $50K in Q3 2020.
  • 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.